喉切除术后二期气管食管穿刺增加分流与发声假体并发症
多因素分析显示,辅助放疗后二期放置假体(HR 3.66)或原发手术后二期放置(HR 2.57)是TEP/VP无并发症生存的独立预测因素。结论建议在初次手术时或放疗前放置假体。
要点
- TEP并发症常见(65.2%),唾液漏最常见(50.0%)。
- 辅助放疗后二期放置假体并发症风险显著增加(HR 3.66)。
- 建议在初次手术时或放疗前放置假体,辅助放疗非禁忌。
核心结论
- 原发手术后二期放置假体、放疗后放置及带蒂皮瓣重建是TEP/VP无并发症生存的不良预测因素。
- 计划性辅助放疗不是TEP假体放置的禁忌证,但应在初次手术时或至少放疗前放置假体。
研究设计与样本
- 采用多因素逻辑回归分析确定与TEP/VP无并发症生存相关的因素。
主要发现
- 多数患者为男性(92.9%),pT3占26.8%,pT4占58.1%,N+占53.6%。
- 所有患者均以喉切除为主要治疗,75%接受辅助放疗或放化疗。
- TEP并发症发生率为65.2%,最常见为唾液漏(50.0%),也是更换假体最常见原因。
- 单因素分析中,辅助放疗后放置假体(HR 4.17,95%CI 2-8.69)、原发手术后二期放置(HR 3.97,95%CI 1.99-7.9)和带蒂皮瓣重建(HR 1.96,95%CI 0.99-3.89)为显著预后因素。
- 多因素分析显示,辅助放疗后二期放置(HR 3.66,95%CI 1.39-9.68)或原发手术后二期放置(HR 2.57,95%CI 0.92-7.2)是TEP/VP无并发症生存降低的最强预测因素。
关键数值与推荐
- TEP并发症发生率65.2%,唾液漏发生率50.0%。
- 辅助放疗后二期放置假体HR 3.66(95%CI 1.39-9.68)。
- 原发手术后二期放置假体HR 2.57(95%CI 0.92-7.2)。
临床怎么用
- 对于计划行喉切除及辅助放疗的患者,应尽量在初次手术时或放疗前放置发声假体。
- 对带蒂皮瓣重建或需二期放置的患者,应加强并发症监测与假体维护。
局限性
- 回顾性研究设计,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate the demographics, clinical features, management, and prognostic indicators of tracheoesophageal puncture complications in patients undergoing placement of voice prosthesis following cancer treatment. STUDY DESIGN: Retrospective analysis. METHODS: A retrospective analysis was conducted of cases from a tertiary referral center diagnosed between 1996 and 2015. Multivariate logistic regression was used to determine factors associated with tracheoesophageal puncture (TEP) and voice prostheses-complication-free survival (TEP/VP-CFS). RESULTS: One hundred fourteen cases were identified. Most patients were males (92.9%) with pT3 (26.8%) or pT4 (58.1%) N+ (53.6%) tumors. All patients received laryngectomy as the primary treatment, with 75% of patients receiving adjuvant radiation therapy or chemoradiotherapy. Complications with TEP were common (65.2%). The most frequent problem was salivary leakage (50.0%), which at the same time was the most common reason for changing the prosthesis. On univariate regression analysis, prosthesis placement time after adjuvant radiotherapy (hazard ratio [HR]: 4.17, 95% confidence interval [CI]: 2-8.69), secondary prosthesis placement after primary surgery (HR: 3.97, 95% CI: 1.99-7.9), and laryngectomy with flap reconstruction (HR: 1.96, 95% CI: 0.99-3.89) were significant prognosticators for complications. Multivariate regression analysis revealed secondary prosthesis placement after adjuvant radiotherapy (HR: 3.66, 95% CI: 1.39-9.68) or after primary surgery (HR: 2.57, 95% CI: 0.92-7.2) to be the strongest predictors of reduced TEP/VP-CFS. CONCLUSIONS: Secondary prosthesis placement after primary surgery, placement after previous irradiation, and laryngectomy with flap reconstruction are predictors of poor TEP/VP-CFS. Planned adjuvant radiotherapy is not a contraindication for TEP with prosthetic placement, but it is very important to place the prosthesis during the primary surgery or at least before scheduled radiotherapy. LEVEL OF EVIDENCE: 4 Laryngoscope, 2020.
引用
- Scherl C, Kauffels J, Schützenberger A, et al. Secondary Tracheoesophageal Puncture After Laryngectomy Increases Complications With Shunt and Voice Prosthesis. Laryngoscope. 2020. PMID: 32027385. doi:10.1002/lary.28517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。